Weekly injection for type 2 diabetes not controlled by metformin
Part of Hormones & metabolism clinical trials.
This study tests a once-weekly injection (HDM1005) to see if it improves blood sugar control in people with type 2 diabetes who are already taking metformin alone or with an SGLT2 inhibitor. It may help lower your A1C levels and manage your weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes for at least 12 weeks.
- You are currently on a stable dose of metformin (with or without an SGLT2 inhibitor) for at least 12 weeks.
- Your recent A1C (average blood sugar over 3 months) is between 7.5% and 11.0% at screening.
- Your body mass index (BMI) is 22.5 kg/m2 or higher.
- You have not had serious diabetes complications, severe low blood sugar, or certain thyroid or pancreas issues in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This study tests an investigational drug called HS-20094 to see how well it controls blood sugar in people with type 2 diabetes. It may help you manage your diabetes better if diet and exercise alone are not enough.
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
This study tests an investigational injectable medication (HRS-4729) to see if it can improve blood sugar control in people with type 2 diabetes. It is for patients who are not on many diabetes medications yet, and the trial monitors safety and effectiveness over time.
This study tests a new medicine called HS-20094 for people with type 2 diabetes. It aims to see if it helps lower blood sugar and may also help with weight. You may be able to join if you are currently on metformin or metformin plus an SGLT-2 inhibitor.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.